A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Associate Director of Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeUnited States$185.3k - $250.7kIn-person

About the Job

Requirements

  • A Ph.D. in Biostatistics or Statistics, or equivalent, with at least 7 years of pharmaceutical biostatistics experience; or an MS with at least 10 years of relevant experience.
  • Excellent written and oral communication and presentation skills.
  • Experience programming in SAS.
  • Interest in and basic understanding of biology and biological processes, including RNA interference (RNAi).

Responsibilities

  • Represent biostatistics at cross-functional team meetings to drive clinical development of drug candidates and provide input on clinical development plans.
  • Collaborate with Clinical Development, Regulatory, and Clinical Operations teams to design clinical trials.
  • Write statistical sections of clinical trial protocols, consulting with internal and external experts.
  • Contribute to or prepare statistical analysis plans.
  • Collaborate with Data Management, Clinical Development, and Clinical Operations on electronic case report form (eCRF) design.
  • Provide statistical guidance on the conduct of ongoing trials.
  • Collaborate with Statistical Programmers on summary and analysis of trial data.
  • Write analysis data set (ADS) and ad hoc analysis specifications.
  • Contribute to clinical study reports and other regulatory documents, including DSURs and briefing documents.
  • Represent Alnylam in meetings with regulators, key opinion leaders, partners, and other stakeholders.
  • Contribute to scientific articles summarizing data collected in Alnylam trials.
  • Participate in other activities and meetings to support Biostatistics and the Development Team as needed.
  • Consult with Research and Preclinical colleagues on statistical questions in their work.
  • Manage contract research organization (CRO) statistical and programming support.

Desired Qualifications

  • Experience in clinical development through Phase 3, including new drug application (NDA) submission.
  • Experience as lead statistician for a compound.
  • Understanding of International Council for Harmonisation Good Clinical Practice (ICH GCP), as well as general knowledge of industry practices and standards.
  • Proficiency in the R programming language and other statistical software, including EAST.
  • Experience with Clinical Data Interchange Standards Consortium (CDISC), including Study Data Tabulation Model (SDTM), Analysis Data Model (ADaM), and Clinical Data Acquisition Standards Harmonization (CDASH).
  • Experience representing sponsors in meetings involving interaction with the U.S. Food and Drug Administration (FDA) and international regulatory authorities.
  • Experience designing and conducting adaptive trials.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs